Janux Therapeutics, Inc. (JANX) Operating cash flow 2020–2025
Janux Therapeutics, Inc. (JANX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$82.2MFY2025 · since FY2020: -$4.4M → -$82.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$82.2M | -87.7% |
| FY2024 | -$43.8M | +13.4% |
| FY2023 | -$50.6M | -17.8% |
| FY2022 | -$42.9M | -152.8% |
| FY2021 | -$17.0M | -288.6% |
| FY2020 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JANX financial trends
JANX RevenueJANX Net incomeJANX Net marginJANX Gross profitJANX Gross marginJANX Operating incomeJANX Operating marginJANX Free cash flowJANX Capital expendituresJANX Return on equityJANX Stock buybacksJANX Dividends paidJANX Total assetsJANX Total liabilitiesJANX Shareholders’ equityJANX overview →